Skip to main content
SpringerLink
Log in

Medikamentöse Therapie der Colitis ulcerosa

  • Chapter
Morbus Crohn Colitis ulcerosa

  • 60 Accesses

Zusammenfassung

Die Colitis ulcerosa ist durch keine konservative Maßnahme zu heilen. Die medikamentöse Therapie hat das Ziel, durch Verringerung der Entzündungsaktivität die Symptomatik zu verbessern, die Lebensqualität des Patienten zu steigern und das Auftreten von Rezidiven zu verhindern. Die Wahl der Therapie muß sich dabei an der Krankheitsaktivität und dem Vorhandensein von Komplikationen orientieren. Darüber hinaus wird die therapeutische Strategie von der Lokalisation und der Ausdehnung der Entzündung beeinflußt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adler DJ, Korelitz BI (1990) The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol 85:717–722

    PubMed  CAS  Google Scholar 

  • Baron JH, Connell PM, Lennard-Jones JE et al. (1962) Sulphasalazine and salicylazonsulphadimidine in ulcerative colitis. Lancet I:1094–1096

    Article  Google Scholar 

  • Burke DA Axon ATR, Clayden SA et al. (1990) The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Therap 4:123–129

    Article  CAS  Google Scholar 

  • Campieri M, De Franchis R, Bianchi Porro G et al. (1990) Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis, Scan J Gastroenterol 25:663–668

    Article  CAS  Google Scholar 

  • Campieri M, Gionchetti P, Belluzzi A et al. (1991) Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 31:929–931

    Article  Google Scholar 

  • Collawn C, Rubin P, Perez N et al. (1992) Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis. Am J Gastroenterol 87:342–436

    PubMed  CAS  Google Scholar 

  • Danish 5-ASA Group (1987) Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. Dig Dis Sci 32:598–602

    Article  Google Scholar 

  • Danielsson Å, Löfberg R, Persson T et al. (1992) Asteroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol 27:9–12

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg AL, Beck LS, McIntosh TM et al. (1988) Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas: A double-blind, placebo-controlled trial. Ann Intern Med 108:195–199

    PubMed  CAS  Google Scholar 

  • Järnerot G, Rolny P, Sandberg-Gertzen H (1985) Intensive intravenous treatment of ulcerative colitis. Gastroenterology 89:1005–1013

    PubMed  Google Scholar 

  • Laursen LS, Naesdal J, Bukhave K et al. (1990) Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 335:683–684

    Article  PubMed  CAS  Google Scholar 

  • Lennard-Jones JE, Longmore AJ, Newel AC et al. (1960) An assessment of prednisone, salazopyrine, and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis. Gut 1:217–222

    Article  PubMed  CAS  Google Scholar 

  • Levine DS, Fischer SH, Christie DL et al. (1992) Intrevenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn’s colitis. Am J Gastroenterol 87:91–100

    PubMed  CAS  Google Scholar 

  • Lichtiger S, Present DH (1990) Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 336:16–19

    Article  PubMed  CAS  Google Scholar 

  • Meyers S, Sachar DB, Goldberg JD et al. (1983) Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology 85:351–357

    PubMed  CAS  Google Scholar 

  • Meyers S, Sachar DB, Present DH et al. (1987) Olsalazine sodium in the treatment of ulcerative colitis among patients intoleran of sulfasalazine. Gastroenterology 93:1255–1262

    PubMed  CAS  Google Scholar 

  • Miner PB Jr, Biddle WL (1990) Maintaining remission in distal ulcerative colitis and ulcerative proctitis. Can J Gastroenterol 4:476–480

    Google Scholar 

  • Rachmilewitz D (International study group) (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 298:82–86

    Article  CAS  Google Scholar 

  • Ruddell WSJ, Dickinson RJ, Dixon MF et al. (1980) Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 21:885–889

    Article  PubMed  CAS  Google Scholar 

  • Rutgeerts P (1989) Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. Aliment Pharmacol Therap 3:183–191

    Article  CAS  Google Scholar 

  • Salomon P, Kronbluth AA, Janowith HD (1990) Treatment of ulcerative colitis with fish oil n-3-ω-fatty acid: an open trial. J Clin Gastroenterol 12:157–161

    Article  PubMed  CAS  Google Scholar 

  • Scheppach W, Sommer H, Kirchner T et al. (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51–56

    PubMed  CAS  Google Scholar 

  • Sninsky CA, Cort DH, Shanahan F et al. (1991) Oral mesalamine (asacol) for mildly to moderatly active ulcerative colitis. Ann Intern Med 115:350–355

    PubMed  CAS  Google Scholar 

  • Sutherland LR, Robinson M, Onstad G et al. (1990) A double-blind, placebo controlled, multicentre study of the efficacy and safety of 5-aminosalicyl acid tablets on the treatment of ulcerative colitis. Can J Gastroenterol 4:463–467

    Google Scholar 

  • Sutherland LR, Martin F, Greer S et al. (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894–1898

    PubMed  CAS  Google Scholar 

  • Suzuki R, Toda H, Takamura Y (1989) Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 59:162–164

    Article  PubMed  CAS  Google Scholar 

  • Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2:1041–1048

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik, Universität Ulm, Robert-Koch-Straße 8, Ulm, Deutschland

    Professor Dr. Guido Adler

Authors
  1. Professor Dr. Guido Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adler, G. (1993). Medikamentöse Therapie der Colitis ulcerosa. In: Morbus Crohn Colitis ulcerosa. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97440-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97440-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97441-0

  • Online ISBN: 978-3-642-97440-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation